GlassScriptPhysician profile
Carrin Brown
NPI 1992357313
$1,121.95
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,098 · 2022: $24.30.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $202.00 | 2021 | |
| Abbvie INC. | $150.32 | 2021 | |
| Glaxosmithkline, LLC. | $133.38 | 2021 | |
| Novo Nordisk INC | $118.46 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $83.04 | 2021 | |
| Eisai INC. | $64.35 | 2021 | |
| Amarin Pharma, INC. | $64.30 | 2021 | |
| Astellas Pharma US INC | $47.16 | 2021 | |
| Janssen Pharmaceuticals, INC | $38.23 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $36.14 | 2021 | |
| Sanofi-Aventis U.S. LLC | $35.26 | 2021 | |
| Ibsa Pharma INC. | $34.22 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $24.21 | 2021 | |
| Abbott Laboratories | $21.22 | 2021 | |
| Pfizer INC. | $18.29 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $14.08 | 2021 | |
| Xeris Pharmaceuticals, INC. | $13.03 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $12.52 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.74 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrin Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.